Clinical Trials Directory

Trials / Terminated

TerminatedNCT01720056

Verapamil vs Steroid to Prevent Keloid Recurrence

Assessment of Verapamil as an Adjunct for Prevention of Keloid Recurrence After Surgical Removal

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
14 (actual)
Sponsor
The University of Western Australia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Keloid scarring is a severe cosmetic and painful disease of the skin. The gold standard treatment is yet to be clarified. This randomized clinical pilot study will compare the effects of two local treatments for preventing keloid recurrence after surgical removal; steroid and verapamil. Study hypothesis: Intralesional therapy with the calcium antagonist verapamil has equal treatment efficacy as steroid injection.

Conditions

Interventions

TypeNameDescription
DRUGVerapamil
DRUGKenalog 10

Timeline

Start date
2012-10-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2012-11-01
Last updated
2015-06-10

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT01720056. Inclusion in this directory is not an endorsement.

Verapamil vs Steroid to Prevent Keloid Recurrence (NCT01720056) · Clinical Trials Directory